Sandra Moreno

Prof. Sandra Moreno

Department of Biology, Università Degli Studi Roma Tre, Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2010 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
MDMarcello D'Amelio
Marcello D'Amelio
VCVirve Cavallucci
Virve Cavallucci
Silvia MiddeiSilvia Middei
Silvia Middei
CMCristina Marchetti
Cristina Marchetti
SPSimone Pacioni
Simone Pacioni
FCFrancesco Cecconi
Francesco Cecconi

1 January 2004 in Neuroscience
Verified
Journal Article
Closed access
Sandra MorenoSandra Moreno
Sandra Moreno
SVstefano farioli vecchioli
stefano farioli vecchioli
MCM.P Cerù
M.P Cerù

16 August 2002 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
PMP G Mastroberardino
P G Mastroberardino
CIC Iannicola
C Iannicola
Roberta NardacciRoberta Nardacci
Roberta Nardacci
FBF Bernassola
F Bernassola
VLVincenzo De Laurenzi
Vincenzo De Laurenzi
MPMauro Piacentini
Mauro Piacentini
By crossing Huntington's disease (HD) R6/1 transgenic mice with ‘tissue’ transglutaminase (TG2) knock-out mice, we have demonstrated that this multifunctional enzyme plays an important role in the neuronal death characterising this disorder in vivo. In fact, a large reduction in cell death is observed in R6/1, TG2−/− compared with R6/1 transgenic mice. In addition, we have shown that the formation of neuronal intranuclear inclusions (NII) is potentiated in absence of the ‘tissue’ transglutaminase. These phenomena are paralleled by a significant improvement both in motor performances and survival of R6/1, TG2−/− versus R6/1 mice. Taken together these findings suggest an important role for tissue transglutaminase in the regulation of neuronal cell death occurring in Huntington's disease.

1 May 2016 in Cell Reports
Verified
Journal Article
Open access
SSSara Sepe
Sara Sepe
CMChiara Milanese
Chiara Milanese
SGSylvia Gabriels
Sylvia Gabriels
KDKasper W.J. Derks
Kasper W.J. Derks
CPCesar Payan
Cesar Payan
PMPier G. Mastroberardino
Pier G. Mastroberardino
The underlying relation between Parkinson's disease (PD) etiopathology and its major risk factor, aging, is largely unknown. In light of the causative link between genome stability and aging, we investigate a possible nexus between DNA damage accumulation, aging, and PD by assessing aging-related DNA repair pathways in laboratory animal models and humans. We demonstrate that dermal fibroblasts from PD patients display flawed nucleotide excision repair (NER) capacity and that Ercc1 mutant mice with mildly compromised NER exhibit typical PD-like pathological alterations, including decreased striatal dopaminergic innervation, increased phospho-synuclein levels, and defects in mitochondrial respiration. Ercc1 mouse mutants are also more sensitive to the prototypical PD toxin MPTP, and their transcriptomic landscape shares important similarities with that of PD patients. Our results demonstrate that specific defects in DNA repair impact the dopaminergic system and are associated with human PD pathology and might therefore constitute an age-related risk factor for PD.

1 February 2012 in Autophagy
Verified
Journal Article
Closed access
Maria ViscomiMaria Viscomi
Maria Viscomi
MDMarcello D’amelio
Marcello D’amelio
VCVirve Cavallucci
Virve Cavallucci
LLLaura Latini
Laura Latini
EBElisa Bisicchia
Elisa Bisicchia
MMMarco Molinari
Marco Molinari
Autophagy is the evolutionarily conserved degradation and recycling of cellular constituents. In mammals, autophagy is implicated in the pathogenesis of many neurodegenerative diseases. However, it...

Verified
Journal Article
Open access
PDF file
AMAIMEE RACHEL MATHEW
AIMEE RACHEL MATHEW
Giacomo Di MatteoGiacomo Di Matteo
Giacomo Di Matteo
PRPiergiorgio La Rosa
Piergiorgio La Rosa
SBSaviana Antonella Barbati
Saviana Antonella Barbati
Luisa ManninaLuisa Mannina
Luisa Mannina
Marco FidaleoMarco Fidaleo
Marco Fidaleo
Vitamin B12 (VitB12) is a micronutrient and acts as a cofactor for fundamental biochemical reactions: the synthesis of succinyl-CoA from methylmalonyl-CoA and biotin, and the synthesis of methionine from folic acid and homocysteine. VitB12 deficiency can determine a wide range of diseases, including nervous system impairments. Although clinical evidence shows a direct role of VitB12 in neuronal homeostasis, the molecular mechanisms are yet to be characterized in depth. Earlier investigations focused on exploring the biochemical shifts resulting from a deficiency in the function of VitB12 as a coenzyme, while more recent studies propose a broader mechanism, encompassing changes at the molecular/cellular levels. Here, we explore existing study models employed to investigate the role of VitB12 in the nervous system, including the challenges inherent in replicating deficiency/supplementation in experimental settings. Moreover, we discuss the potential biochemical alterations and ensuing mechanisms that might be modified at the molecular/cellular level (such as epigenetic modifications or changes in lysosomal activity). We also address the role of VitB12 deficiency in initiating processes that contribute to nervous system deterioration, including ROS accumulation, inflammation, and demyelination. Consequently, a complex biological landscape emerges, requiring further investigative efforts to grasp the intricacies involved and identify potential therapeutic targets.